911-12 Silvercord Tower 2 30 Canton Road,
Tsim Sha Tsui,
C&O is an integrated pharmaceutical group in China. Its activities span research & development, manufacturing, and marketing and distribution of C&O and third party brand products.
C&O Pharmaceutical Technology Holdings was acquired by Shionogi & Co on August 01, 2011.
Join Mergr to view all 307 acquisitions of healthcare services companies in 2011, including 74 acquisitions by private equity firms, and 233 by strategics.
Out of 60 sectors in the Mergr database, healthcare services ranked 4 in number of deals in 2011. The largest healthcare services acquisition in 2011 was Pharmaceutical Product Development - which was acquired by Hellman & Friedman for $3.9B.
Join Mergr to view this profile - and discover more healthcare services acquisitions of companies like C&O Pharmaceutical Technology Holdings.
No obligation. Cancel anytime.